StateFederal Regulatory Clash Escalates Over Prediction Markets 16 States Pursue Legal Action Suzlon Energy Reports Strong Q4 Revenue Growth Eyes Renewable Expansion Samsung Chip Workers Poised for Record Bonuses as AI Demand Drives Semiconductor Profits Pinterest Faces Analyst Scrutiny Amid Evolving Digital Advertising Landscape Walmart Kroger and ELF Beauty Announce Price Cuts Potential Margin Pressures Ahead EOG Resources Soared in Q1 Oil Price Rally and Operational Strength Drive Gains NRX Pharmaceuticals Q1 2026 Earnings EPS Miss Marks 114 Surprise Shortfall Stock Surges 20 FUNC Q1 2026 Earnings EPS Surpasses Estimates by 87 Amid Solid Operating Performance Kairos Pharma Ltd KAPA Q1 2026 Earnings EPS Misses Estimates Amid Ongoing ClinicalStage Operations SPOK Q1 2026 Earnings EPS Misses Estimates by a Wide Margin Stock Slips Axsome Therapeutics Q1 2026 Earnings WiderThanExpected Loss Weighs on Sentiment EGO Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response MFAO Holds Steady Near 2520 as Senior Notes Trade in Tight Range Gain Therapeutics GANX Surges 147 as Volume Picks Up Testing Resistance at 213 MIND CTI MNDO Bounces 326 Nearing Key Resistance at 10 Invesco Municipal Trust VKQ Edges Higher as Bond Market Stabilizes Essential Utilities WTRG Edges Higher Amid Defensive Positioning UK Chancellor Rachel Reeves Unveils VAT Cut on Summer Leisure A Surprise CostofLiving Measure PIII Q1 2026 Earnings Massive EPS Beat Drives Surprise Profitability Yet Stock Declines Praetorian Acquisition Corp PTOR Holds Steady Near Support Amid Muted Activity Planet Green Holdings PLAG Holds Steady at 163 as Tight Trading Range Persists Murano Global Investments MRNO Bounces from 030 Support Key Levels to Watch GRAIL Inc GRAL Surges 56 as Momentum Builds Toward Key Resistance Franklin Resources BEN Holds Steady Near Key Support as Asset Manager Faces Headwinds PureCycle Technologies Unit PCTTU Holds Steady at 620 as Traders Eye Key Support and Resistance Levels Pelican Acquisition PELI Shares Tumble 1179 Support Levels in Focus Fulcrum Therapeutics FULC Edges Higher as Biotech Sentiment Stabilizes